Gossamer Bio Inc (GOSS) — Cash Flow-to-Debt Ratio
Gossamer Bio Inc (GOSS) has a Cash Flow-to-Debt Ratio of -0.12x as of September 2025, meaning its operating cash flow of $-36.17 Million could theoretically repay 0% of its total liabilities ($291.15 Million) in one year. See Gossamer Bio Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Gossamer Bio Inc Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for Gossamer Bio Inc across 9 annual periods. Also explore Gossamer Bio Inc (GOSS) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Gossamer Bio Inc (2016–2024)
Year-by-year debt coverage analysis for Gossamer Bio Inc. For market capitalisation and broader financial context, see Gossamer Bio Inc stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.01x | $-3.47 Million | $285.80 Million | ▲ +98.1% |
| 2023 | -0.64x | $-159.16 Million | $249.15 Million | ▲ +11.1% |
| 2022 | -0.72x | $-187.03 Million | $260.37 Million | ▲ +15.5% |
| 2021 | -0.85x | $-188.89 Million | $222.19 Million | ▼ -5.4% |
| 2020 | -0.81x | $-176.36 Million | $218.75 Million | ▲ +58.7% |
| 2019 | -1.95x | $-144.83 Million | $74.12 Million | ▼ -1276.2% |
| 2018 | -0.14x | $-51.04 Million | $359.49 Million | ▲ +81.9% |
| 2017 | -0.79x | $-5.75 Million | $7.31 Million | ▼ -819.4% |
| 2016 | 0.11x | $20.00K | $183.00K | — |